References
- ACOG Committee Opinion 514: Emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. December 2011. Obstet Gynecol 2011;118:1465–8
- McGee W, Springfield M, Boston M, et al. Critical care issues for the nephrologist: the pulmonary artery catheter in critical care. Semin Dialysis 2006;19:480–91
- Burlingame J, Ohana P, Aaronoff M, Seto T. Noninvasive cardiac monitoring in pregnancy: impedance cardiography versus echocardiography. J Perinatol 2013;9:675–80
- Tomsin K, Mesens T, Molenberghs G, Gyselaers W. Impedance cardiography in uncomplicated pregnancy and pre-eclampsia: a reliability study. J Obstet Gynaecol 2012;32:630–4
- San-Frutos L, Engels V, Zapardiel I, et al. Hemodynamic changes during pregnancy and postpartum: a prospective study using thoracic electrical bioimpedance. J Mat Fetal Neo Med 2011;24:1333–40
- Parrish M, Laye M, Wood T, et al. Impedance cardiography facilitates differentiation of severe and superimposed preeclampsia from other hypertensive disorders. Hypertens Preg 2012;31:327–40
- Easterling T. Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth. Obstet Gynecol 2001;98:427–33
- Morris R, Sunesarra IR, Rush L, et al. Maternal hemodynamics by thoracic impedance cardiography for normal pregnancy and postpartum. Obstet Gynecol 2014;123:318–24
- Staelens A, Tomsin K, Grieten L, et al. Non-invasive assessment of gestational hemodynamics: benefits and limitations of impedance cardiography versus other techniques. Expert Rev Med Devices 2013;10:765–79
- Harris P, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81
- StataCorp. 2011. Stata Statistical Software: Release 12. College Station (TX): StataCorp LP
- Easterling TR, Benedetti TJ, Schmucker BC, Millard SP. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol 1990;76:1061–9
- Severe Pre-Eclampsia/Eclampsia, Management (Green-top 10A). Available from: http://www.rcog.org.uk/womens-health/clinical-guidance/management-severe-pre-eclampsiaeclampsia-green-top-10a [last accessed 13 Aug 2014]
- Magee L, Helewa M, Dadelszen von P, Moutquin J. Diagnosis, evaluation and management of the hypertensive disorders of pregnancy. sogc.org. 206. Available from: http://sogc.org/guidelines/diagnosis-evaluation-and-management-of-the-hypertensive-disorders-of-pregnancy/ [last accessed 13 Aug 2014]
- Lindheimer M, Taler S, Cunningham F. Hypertension in pregnancy. J Am Soc Hyperten 2008;2:484–494
- Lowe S, Brown M, Dekker G, et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol 2009;49:242–6
- Steegers E, Dadelszen P, Duvekot J, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:631–44
- Shekhar S, Sharma C, Thakur S, Verma S. Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial. Obstet Gynecol 2013;122:1057–63
- Vidt DG, Bakst A, Pearce CJ, Wallin JD. Labetalol and other agents that block both alpha- and beta-adrenergic receptors. Cleveland Clin J Med 1994;61:59–69
- Ludden T, Shepherd A, McNay J, Lin M. Hydralazine kinetics in hypertensive patients after intravenous administration. Clin Pharm Ther 1980;28:736–42
- Magee L. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. Br Med J 2003;327:955–60
- Magee LA, Miremadi S, Li J, et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 2005;193:153–63
- Flo K, Wilsgaard T, Vårtun Å, Acharya G. A longitudinal study of the relationship between maternal cardiac output measured by impedance cardiography and uterine artery blood flow in the second half of pregnancy. BJOG 2010;117:837–44
- Oehm E, Hetzel A, Els T, et al. Cerebral hemodynamics and autoregulation in reversible posterior leukoencephalopathy syndrome caused by pre-eclampsia. Cerebr Dis 2006;22:204–8